Despite the fact that our understanding of the clinical, molecular and pathologic characteristics of PCa is incomplete, the androgen receptor (AR), which is regarded as the primary oncoprotein in PCa and CRPC, is regularly expressed in a heterogeneous way, even in the context of AR gene amplification.3 Here, AR is linked to posterior cortical atrophy.